ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,100.54
      1.46%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      07/27/20217:33PMBenzingaEarning Reports Fom Household Names This Week. PART 1NYSE:ABBVAbbVie Inc
      07/27/20218:30AMPR Newswire (US)AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related DiseasesNYSE:ABBVAbbVie Inc
      07/26/20216:42AMDow Jones NewsAbbVie Eye Drug AGN-190584 Meets Endpoints in Phase 3 StudyNYSE:ABBVAbbVie Inc
      07/25/202111:31AMPR Newswire (US)New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye ConditionNYSE:ABBVAbbVie Inc
      07/23/20211:27PMDow Jones NewsAbbVie Gets FDA OK for Pediatric Skin Infection DrugNYSE:ABBVAbbVie Inc
      07/23/202112:37PMPR Newswire (US)DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric PatientsNYSE:ABBVAbbVie Inc
      07/21/20211:00AMPR Newswire (US)Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS)NYSE:ABBVAbbVie Inc
      07/20/20218:30AMPR Newswire (US)Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of C...NYSE:ABBVAbbVie Inc
      07/16/20219:09AMDow Jones NewsAbbVie Says FDA Didn't Meet Action Date for Dermatitis Treatment ApplicationNYSE:ABBVAbbVie Inc
      07/16/20218:30AMPR Newswire (US)AbbVie Provides Update Regarding RINVOQ® (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S...NYSE:ABBVAbbVie Inc
      07/08/20214:06PMGlobeNewswire Inc.Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Gene...NYSE:ABBVAbbVie Inc
      07/07/20218:00AMPR Newswire (US)AbbVie to Host Second-Quarter 2021 Earnings Conference CallNYSE:ABBVAbbVie Inc
      07/02/20219:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      07/02/20219:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      07/02/20219:09AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      06/29/20219:05AMDow Jones NewsAbbVie Upadacitinib Trial Meets Primary, Secondary EndpointsNYSE:ABBVAbbVie Inc
      06/29/20218:00AMPR Newswire (US)Upadacitinib (RINVOQ®) Met the Primary and All Secondary Endpoints in the 52-Week Phase 3 Maintenance Study in Ulcerative Co...NYSE:ABBVAbbVie Inc
      06/28/20218:45AMPR Newswire (US)AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of European Crohn's and Colitis Organisation (ECCO)NYSE:ABBVAbbVie Inc
      06/28/20218:34AMTipRanksFDA Will Not Meet PDUFA Action Dates for AbbVie’s Rinvoq: ReportNYSE:ABBVAbbVie Inc
      06/25/202110:25AMDow Jones NewsAbbVie Says FDA Won't Meet Action Dates for Arthritis Drug RinvoqNYSE:ABBVAbbVie Inc
      06/25/20218:30AMPR Newswire (US)AbbVie Provides Update Regarding RINVOQ® (upadacitinib) in Psoriatic Arthritis and Ankylosing Spondylitis in the U.S.NYSE:ABBVAbbVie Inc
      06/25/20212:30AMPR Newswire (US)CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic DermatitisNYSE:ABBVAbbVie Inc
      06/24/20218:00AMPR Newswire (US)AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Mult...NYSE:ABBVAbbVie Inc
      06/21/20214:03PMEdgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:ABBVAbbVie Inc
      06/21/20214:02PMEdgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:ABBVAbbVie Inc
      06/17/20216:29PMPR Newswire (US)AbbVie Declares Quarterly DividendNYSE:ABBVAbbVie Inc
      06/12/20217:02AMPR Newswire (US)IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compar...NYSE:ABBVAbbVie Inc
      06/11/20217:32AMDow Jones NewsAbbVie Sees Continued Positive Results for Leukemia TreatmentNYSE:ABBVAbbVie Inc
      06/11/20211:03AMPR Newswire (US)New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival i...NYSE:ABBVAbbVie Inc
      06/08/20218:45AMPR Newswire (US)Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New CampaignNYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV